Narrative Review of Postural Orthostatic Tachycardia Syndrome: Associated Conditions and Management Strategies

Overview

Journal US Cardiol

Date 2024 Nov 19

PMID 39559520

Authors

Rebecca S Steinberg

Weston Dicken

Alexis Cutchins

Affiliations

Soon will be listed here.

Abstract

Postural orthostatic tachycardia syndrome (POTS) is a heterogeneous disorder that presents with positional tachycardia and a constellation of other symptoms. Peer-reviewed evidence for treatment options is limited. In addition, there are various associated conditions with overlapping symptoms. These factors can make the diagnosis and management of POTS a frustrating experience for both providers and patients. This paper aims to combine available scientific data with anecdotal evidence derived from extensive clinical experience to provide information on recognizing the clinical features of POTS, identifying associated conditions, and understanding treatment strategies to help providers better diagnose and manage patients with this condition.

References

Joseph P, Pari R, Miller S, Warren A, Stovall M, Squires J . Neurovascular Dysregulation and Acute Exercise Intolerance in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Randomized, Placebo-Controlled Trial of Pyridostigmine. Chest. 2022; 162(5):1116-1126. DOI: 10.1016/j.chest.2022.04.146. View

Shaw B, Stiles L, Bourne K, Green E, Shibao C, Okamoto L . The face of postural tachycardia syndrome - insights from a large cross-sectional online community-based survey. J Intern Med. 2019; 286(4):438-448. PMC: 6790699. DOI: 10.1111/joim.12895. View

Peggs K, Nguyen H, Enayat D, Keller N, Al-Hendy A, Raj S . Gynecologic disorders and menstrual cycle lightheadedness in postural tachycardia syndrome. Int J Gynaecol Obstet. 2012; 118(3):242-6. PMC: 3413773. DOI: 10.1016/j.ijgo.2012.04.014. View

Green E, Raj V, Shibao C, Biaggioni I, Black B, Dupont W . Effects of norepinephrine reuptake inhibition on postural tachycardia syndrome. J Am Heart Assoc. 2013; 2(5):e000395. PMC: 3835251. DOI: 10.1161/JAHA.113.000395. View

Dodson C, Bagai K, Weinstock L, Thompson E, Okamoto L, Peltier A . Restless legs syndrome is increased in postural orthostatic tachycardia syndrome. J Clin Sleep Med. 2020; 17(4):791-795. PMC: 8020678. DOI: 10.5664/jcsm.9020. View

Deng X, Zhang Y, Liao Y, Du J . Efficacy of β-Blockers on Postural Tachycardia Syndrome in Children and Adolescents: A Systematic Review and Meta-Analysis. Front Pediatr. 2019; 7:460. PMC: 6854016. DOI: 10.3389/fped.2019.00460. View

Miller A, Raj S . Pharmacotherapy for postural tachycardia syndrome. Auton Neurosci. 2018; 215:28-36. DOI: 10.1016/j.autneu.2018.04.008. View

Shoenfeld Y, Ryabkova V, Scheibenbogen C, Brinth L, Martinez-Lavin M, Ikeda S . Complex syndromes of chronic pain, fatigue and cognitive impairment linked to autoimmune dysautonomia and small fiber neuropathy. Clin Immunol. 2020; 214:108384. DOI: 10.1016/j.clim.2020.108384. View

Ruzieh M, Sirianni N, Ammari Z, Dasa O, Alhazmi L, Karabin B . Ivabradine in the treatment of postural tachycardia syndrome (POTS), a single center experience. Pacing Clin Electrophysiol. 2017; 40(11):1242-1245. DOI: 10.1111/pace.13182. View

10.

Mar P, Raj S . Postural Orthostatic Tachycardia Syndrome: Mechanisms and New Therapies. Annu Rev Med. 2019; 71:235-248. DOI: 10.1146/annurev-med-041818-011630. View

11.

Jarjour I, Jarjour L . Low iron storage and mild anemia in postural tachycardia syndrome in adolescents. Clin Auton Res. 2013; 23(4):175-9. DOI: 10.1007/s10286-013-0198-6. View

12.

Fu Q, Levine B . Exercise and non-pharmacological treatment of POTS. Auton Neurosci. 2018; 215:20-27. PMC: 6289756. DOI: 10.1016/j.autneu.2018.07.001. View

13.

Mueller B, Robinson-Papp J . Postural orthostatic tachycardia syndrome and migraine: A narrative review. Headache. 2022; 62(7):792-800. DOI: 10.1111/head.14365. View

14.

Grubb A, Grubb B . Postural orthostatic tachycardia syndrome: New concepts in pathophysiology and management. Trends Cardiovasc Med. 2021; 33(2):65-69. DOI: 10.1016/j.tcm.2021.10.007. View

15.

Bonamichi-Santos R, Yoshimi-Kanamori K, Giavina-Bianchi P, Aun M . Association of Postural Tachycardia Syndrome and Ehlers-Danlos Syndrome with Mast Cell Activation Disorders. Immunol Allergy Clin North Am. 2018; 38(3):497-504. DOI: 10.1016/j.iac.2018.04.004. View

16.

Sheldon R, Grubb 2nd B, Olshansky B, Shen W, Calkins H, Brignole M . 2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope. Heart Rhythm. 2015; 12(6):e41-63. PMC: 5267948. DOI: 10.1016/j.hrthm.2015.03.029. View

17.

Swai J, Hu Z, Zhao X, Rugambwa T, Ming G . Heart rate and heart rate variability comparison between postural orthostatic tachycardia syndrome versus healthy participants; a systematic review and meta-analysis. BMC Cardiovasc Disord. 2020; 19(1):320. PMC: 6936126. DOI: 10.1186/s12872-019-01298-y. View

18.

Lakkireddy D, Garg J, deAsmundis C, LaMeier M, Romeya A, Vanmeetren J . Sinus Node Sparing Hybrid Thoracoscopic Ablation Outcomes in Patients with Inappropriate Sinus Tachycardia (SUSRUTA-IST) Registry. Heart Rhythm. 2021; 19(1):30-38. DOI: 10.1016/j.hrthm.2021.07.010. View

19.

Kesterson K, Schofield J, Blitshteyn S . Immunotherapy with subcutaneous immunoglobulin or plasmapheresis in patients with postural orthostatic tachycardia syndrome (POTS). J Neurol. 2022; 270(1):233-239. DOI: 10.1007/s00415-022-11344-z. View

20.

Coffin S, Black B, Biaggioni I, Paranjape S, Orozco C, Black P . Desmopressin acutely decreases tachycardia and improves symptoms in the postural tachycardia syndrome. Heart Rhythm. 2012; 9(9):1484-90. PMC: 3419341. DOI: 10.1016/j.hrthm.2012.05.002. View